Obviously PCa in dogs, which we know occurs, isn't something we really need to know about
But as the article linked below makes clear, there are some interspecies similarities between PCa in humans and dogs, so that knowing at least a little about
the workings of the disease in canines may offer us some different perspectives on our own human PCa.
Besides, for those of us who are dog lovers, and who may even own a male one right now, learning at least a bit about
this disease in our pets is useful.
In particular, understanding that many of the symptoms of it in dogs are quite similar to those in men (see article) may enable us better to notice such symptoms when we start to see them happening in our own dogs, and it's time to take Fido to the vet.
The article notes that there are even treatment options that can be followed when PCa is detected in dogs, although it doesn't say whether a specialized vet needs to be consulted, or what the cost of such treatment might be.
From the article:"(canine PCa is) more common in large breeds and older dogs around nine or ten years of age."
"The most common effective treatment for prostate cancer in dogs is a combination of NSAIDs, chemotherapy, and radiation therapy. This can increase survival time an average of 20 months. Incontinence, gastrointestinal toxicosis, or genitourinary toxicosis can be side effects of this treatment."
And I assume an increase in survival time of 20 months in dogs, would, thinking in "dog years," be roughly equivalent to three years in humans? But that's probably apples and oranges.
But the article does give us a little more knowledge about
PCa, how it operates in another species, and maybe as well enables us to feel a little bit of empathy for the faithful companion laying at our feet, when we realize that PCa can be a problem for him too.https://dogtime.com/dog-health/canine-cancer/2996-prostrate-cancer-canine-cancer-library
Chronic prostatitis (age 60 on)
BPH w/ urinary obstruction, 6/2011
Ongoing high PSA, 7/2011-12/2011
Biopsy, 12/2011: positive 3/12 (90%, 70%, 5%)
Gleason 6(3+3), T1c
No mets, PCa likely still organ contained
IMRT w/ HT (Lupron), 4/2012-6/2012
PSAs (since post-IMRT): 0.1 to 0.3 range